Study of CM310 in Patients With Allergic Rhinitis

Clinical trial NCT05908721 · COMPLETED

Trial details

NCT number: NCT05908721
Sponsor: Keymed Biosciences Co.Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2023-08-23
Primary completion: 2023-12-10
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.